Starting up in a garage isn’t an option for life sciences companies that do things like analyze microbes and test saliva samples. They need laboratory space, which is in short supply in Minnesota.

Bio-Techne Corporation, a global provider of life science research tools, analytical instruments, and diagnostics, today ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Bio-Techne (TECH) has expanded its COMET spatial biology platform with new SPYRE ...

Shares of Bio-Techne Corp. TECH rallied 1.26% to $53.80 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.44% to 6,611.83 and ...

Next-generation biomarker discovery and diagnostics Bio-Techne combines expertise in exosome technologies with experience in the non-invasive liquid biopsy market to create solutions for companion ...

Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market open. Here’s what to look for. Bio-Techne missed analysts’ revenue expectations by 1.7% ...

An agtech company is expanding its footprint in the St. Louis region with more than $7 million in new investment and plans to ...

The custom antibody market is projected to grow at a CAGR of approximately 10% throughout the forecast period. This expansion is driven by increasing R&D activity, rising demand for highly specific ...

John Maynard Keynes' insight that investment results rarely match initial expectations underscores the inherent uncertainty ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations ...